| Literature DB >> 30696739 |
Fernando L Leite1, Juan E Abrahante2, Erika Vasquez3, Fabio Vannucci3, Connie J Gebhart1, Nathan Winkelman4, Adam Mueller4, Jerry Torrison3, Zachary Rambo5, Richard E Isaacson6.
Abstract
Lawsonia intracellularis causes porcine proliferative enteropathy. This is an enteric disease characterized by thickening of the wall of the ileum that leads to decreased growth of animals and diarrhea. In this study, we investigated the host response to L. intracellularis infection by performing transcriptomic and pathway analysis of intestinal tissue samples from groups of infected and noninfected animals at 14, 21, and 28 days postchallenge. At the peak of infection, when animals developed the most severe lesions, infected animals had higher levels of several gene transcripts involved in cellular proliferation and inflammation, including matrix metalloproteinase-7 (MMP7), transglutaminase-2 (TGM2), and oncostatin M (OSM). Histomorphology also revealed general features of intestinal inflammation. This study identified important pathways associated with the host response in developing and resolving lesions due to L. intracellularis infection.IMPORTANCE Lawsonia intracellularis is among the most important enteric pathogens of swine, and it can also infect other mammalian species. Much is still unknown regarding its pathogenesis and the host response, especially at the site of infection. In this study, we uncovered several novel genes and pathways associated with infection. Differentially expressed transcripts, in addition to histological changes in infected tissue, revealed striking similarities between L. intracellularis infection and cellular proliferation mechanisms described in some cancers and inflammatory diseases of the gastrointestinal tract. This research sheds important light into the pathogenesis of L. intracellularis and the host response associated with the lesions caused by infection.Entities:
Keywords: Lawsonia intracellulariszzm321990; cell proliferation; host response; intestinal inflammation; transcriptome
Mesh:
Year: 2019 PMID: 30696739 PMCID: PMC6355989 DOI: 10.1128/mBio.01605-18
Source DB: PubMed Journal: mBio Impact factor: 7.867
Measures of infection by L. intracellularis at different times postinfection
| Day | Animal | Score for indicated assay | Serum antibody titer | |||
|---|---|---|---|---|---|---|
| IHC | H&E stain | GL | ||||
| 14 | 139 | 1 | 1 | 0 | 20.02 | Neg |
| 99 | 1 | 1 | 0 | 26.33 | 1:30 | |
| 148 | 1 | 1 | 0 | 29.44 | Neg | |
| 77 | 1 | 1 | 0 | 34.97 | 1:30 | |
| 188 | 1 | 1 | 0 | 26.89 | 1:30 | |
| 87 | 1 | 1 | 0 | 27.54 | 1:30 | |
| Avg | 1.00 | 1.00 | 0.00 | 27.53 | 1:20 | |
| 21 | 144 | 1 | 1 | 0 | 27.11 | 1:480 |
| 173 | 1 | 1 | 0 | 25.51 | 1:240 | |
| 192 | 1 | 1 | 1 | 26.3 | Neg | |
| 297 | 3* | 3* | 1 | 27.08 | 1:240 | |
| 1381 | 4* | 3* | 3 | 17.33 | 1:240 | |
| 97 | 3* | 3* | 1 | 25.04 | 1:240 | |
| Avg | 2.17 | 2.00 | 1.00 | 24.73 | 1:240 | |
| 28 | 94 | 0 | 1 | 1 | Neg | 1:240 |
| 197 | 0 | 0 | 1 | Neg | Neg | |
| 194 | 1 | 1 | 1 | 32.52 | 1:1,920 | |
| 1386 | 2.5* | 3* | 2 | 26.61 | 1:1,920 | |
| 1385 | 2.5* | 2* | 1 | 28.62 | 1:480 | |
| 189 | 4* | 3* | 2 | 23.61 | 1:960 | |
| Avg | 1.67 | 1.67 | 1.33 | 27.84 | 1:920 | |
The measures of infection include immunohistochemistry, microscopic (H&E stain) and gross lesion scores, C value from PCR, and serum antibody titer. Neg, negative result; *, high lesion.
IHC, immunohistochemistry of L. intracellularis antigen in tissue; H&E, hematoxylin and eosin stain of microscopic lesions; GL, gross lesion score.
Serum antibody titer was measured using the immunoperoxidase monolayer assay (IPMA).
FIG 1Histomorphology of ileum tissue. (a) Crypt depth. (b) Villus height. Reported are the mean values and standard errors for each treatment by day. Different letters indicate statistical significance (P < 0.05). Error bars represent standard errors of the means, and open circles indicate the mean values. dpi, days postinfection; I, infected; NI, noninfected; H, high lesion; L, low lesion.
Differentially abundant gene transcripts identified at 21 days postinfection comparing infected to noninfected pigs
| Ensembl ID | Gene symbol | Fold change | Corrected |
|---|---|---|---|
| ENSSSCT00000009326.2 | 816.98 | 0.009 | |
| ENSSSCT00000016344.2 | 409.6 | 0.014 | |
| ENSSSCT00000026800.1 | 277.33 | 0.024 | |
| ENSSSCT00000014604.2 | 198.35 | 3.66E−04 | |
| ENSSSCT00000005396.2 | 128.98 | 0.009 | |
| ENSSSCT00000014601.3 | 92.3 | 0.024 | |
| ENSSSCT00000004241.1 | 58.54 | 0.016 | |
| ENSSSCT00000010382.2 | 28.02 | 0.009 | |
| ENSSSCT00000029653.1 | 25.13 | 0.034 | |
| ENSSSCT00000009811.2 | 23.57 | 0.009 | |
| ENSSSCT00000000312.2 | 23.06 | 0.009 | |
| ENSSSCT00000010954.2 | 19.87 | 0.015 | |
| ENSSSCT00000011519.2 | 18.66 | 0.026 | |
| ENSSSCT00000007675.2 | 17.62 | 0.016 | |
| ENSSSCT00000000001.2 | 15.66 | 0.024 | |
| ENSSSCT00000016351.2 | 15.04 | 0.021 | |
| ENSSSCT00000005162.1 | 13.56 | 0.009 | |
| ENSSSCT00000031001.2 | 11.72 | 0.035 | |
| ENSSSCT00000005163.2 | 10.24 | 0.014 | |
| ENSSSCT00000026673.2 | 7.3 | 0.013 | |
| ENSSSCT00000015915.1 | 4.21 | 0.009 | |
| ENSSSCT00000010573.2 | −4.61 | 0.014 |
FIG 2Venn diagram of differentially abundant gene transcripts compared between infected and noninfected animals at 21 dpi (I versus NI 21 dpi), high- and low-lesion animals at 21 dpi (H versus L 21 dpi), and high- and low-lesion animals at 28 dpi (H versus L 28 dpi).
The 10 most increased and the 10 most decreased transcripts at 21 dpi comparing animals with high and low lesions
| Ensembl ID | Gene symbol | Fold change | Corrected |
|---|---|---|---|
| ENSSSCT00000016344.2 | 1129.1 | 1.04E−05 | |
| ENSSSCT00000027635.1 | 833.28 | 5.29E−05 | |
| ENSSSCT00000026800.1 | 762.53 | 1.08E−04 | |
| ENSSSCT00000005396.2 | 402.41 | 6.44E−14 | |
| ENSSSCT00000017853.2 | 342.92 | 4.13E−03 | |
| ENSSSCT00000002779.1 | 330.73 | 1.12E−02 | |
| ENSSSCT00000000258.2 | 311.53 | 4.92E−03 | |
| ENSSSCT00000012090.2 | 244.63 | 9.47E−05 | |
| ENSSSCT00000005307.1 | 230.45 | 2.62E−02 | |
| ENSSSCT00000017233.2 | 217.36 | 1.00E−02 | |
| ENSSSCT00000028967.1 | −16.92 | 0.017351 | |
| ENSSSCT00000010414.2 | −17.93 | 0.000002 | |
| ENSSSCT00000012033.2 | −20.45 | 0.000621 | |
| ENSSSCT00000010411.2 | −20.46 | 0.011745 | |
| ENSSSCT00000003670.2 | −22.44 | 0.045878 | |
| ENSSSCT00000009346.2 | −23.42 | 0.006509 | |
| ENSSSCT00000016435.2 | −42.21 | 0.000568 | |
| ENSSSCT00000016434.2 | −62.85 | 4.63E−05 | |
| ENSSSCT00000014068.2 | −63.33 | 0.037558 | |
| ENSSSCT00000022909.1 | −239.38 | 0.049848 |
There were 417 increased transcripts and 77 decreased transcripts.
Differentially abundant gene transcripts between high- and low-lesion animals at 28 days postinfection
| Ensembl ID | Gene symbol | Fold change | Corrected |
|---|---|---|---|
| ENSSSCT00000009326.2 | 522.4 | 0.013 | |
| ENSSSCT00000016344.2 | 285.18 | 0.046 | |
| ENSSSCT00000014806.2 | 276.6 | 0.006 | |
| ENSSSCT00000014604.2 | 191.45 | 3.92E−05 | |
| ENSSSCT00000004480.2 | 96.61 | 0.046 | |
| ENSSSCT00000013521.2 | 49.46 | 0.026 | |
| ENSSSCT00000016670.2 | 44.33 | 0.02 | |
| ENSSSCT00000027321.1 | 35.54 | 0.031 | |
| ENSSSCT00000008138.2 | 30.24 | 0.031 | |
| ENSSSCT00000034787.1 | 26.57 | 0.008 | |
| ENSSSCT00000000652.2 | 22.07 | 0.009 | |
| ENSSSCT00000009543.2 | 20.22 | 0.046 | |
| ENSSSCT00000005438.2 | 20 | 0.053 | |
| ENSSSCT00000031001.2 | 19.23 | 0.026 | |
| ENSSSCT00000007675.2 | 18.43 | 0.01 | |
| ENSSSCT00000033135.1 | 14.65 | 0.01 | |
| ENSSSCT00000010999.3 | 13.24 | 3.92E−05 | |
| ENSSSCT00000032543.1 | 11.78 | 0.006 | |
| ENSSSCT00000010515.2 | 11.7 | 0.046 | |
| ENSSSCT00000003426.2 | 8.51 | 0.01 | |
| ENSSSCT00000008224.1 | 5.2 | 0.046 | |
| ENSSSCT00000006735.2 | −44.61 | 0.046 | |
| ENSSSCT00000022705.1 | −166.98 | 0.004 |
List of diseases and functions associated with “proliferation” among the diseases and functions identified between animals with high and low lesions using Ingenuity Pathway Analysis
| Function annotation | z-score | No. of | |
|---|---|---|---|
| Proliferation of connective tissue cells | 4.75E−14 | 3.983 | 50 |
| Cell proliferation of fibroblasts | 4.32E−09 | 3.873 | 29 |
| Proliferation of synovial cells | 5.92E−08 | 2.922 | 9 |
| Cell proliferation of tumor cell lines | 1.4E−15 | 2.671 | 98 |
| Proliferation of stem cells | 0.000014 | 2.52 | 16 |
| Cell proliferation of breast cancer cell lines | 0.000000235 | 2.075 | 32 |
| Proliferation of pericytes | 0.0000125 | 1.71 | 8 |
| Endothelial cell development | 0.000000131 | 1.461 | 27 |
| Proliferation of liver cells | 0.0000153 | 1.25 | 15 |
| Proliferation of tumor cells | 0.0000106 | 1.22 | 28 |
| Proliferation of endothelial cells | 9.05E−08 | 1.142 | 25 |
| Proliferation of epithelial cells | 7.77E−09 | 1.007 | 36 |
| Cell proliferation of ovarian cancer cell lines | 0.00000357 | 0.891 | 13 |
| Colony formation of cells | 4.52E−08 | 0.429 | 34 |
| Colony formation | 1.85E−08 | 0.401 | 37 |
| Colony formation of tumor cell lines | 0.00000122 | −0.537 | 22 |
Activated canonical pathways in animals with high lesions compared to low-lesion animals at 21 days postinfection
| Canonical pathway | −log( | z-score | No. of |
|---|---|---|---|
| Osteoarthritis pathway | 8.31 | 2 | 19 |
| Oncostatin M signaling | 3.62 | 2.236 | 5 |
| Estrogen-mediated S-phase entry | 3.2 | 2 | 4 |
| Aryl hydrocarbon receptor signaling | 2.49 | 2.646 | 8 |
| Leukocyte extravasation signaling | 2.43 | 3.162 | 10 |
| Dendritic cell maturation | 1.79 | 2.828 | 8 |
| Wnt/Ca+ pathway | 1.72 | 2 | 4 |
| Acute-phase response signaling | 1.59 | 2.236 | 7 |
| Chemokine signaling | 1.43 | 2 | 4 |
| Melatonin signaling | 1.38 | 2 | 4 |
The 30 most significant upstream regulators associated with the differentially expressed genes between animals with high and low level of infection
| Upstream regulator | Fold change | Molecule type | z-score | |
|---|---|---|---|---|
| CDKN1A | Kinase | −2.696 | 2.06E−36 | |
| TP53 | Transcription regulator | −1.797 | 9.48E−29 | |
| TGFB1 | Growth factor | 4.163 | 3.51E−28 | |
| ERBB2 | Kinase | 4.368 | 2.57E−26 | |
| TNF | Cytokine | 2.31 | 2.23E−23 | |
| Calcitriol | Chemical—drug | −2.059 | 1.12E−20 | |
| HGF | Growth factor | 3.546 | 1.94E−20 | |
| RABL6 | Other | 4.472 | 4.4E−20 | |
| Lipopolysaccharide | Chemical—drug | 4.252 | 1.22E−19 | |
| CCND1 | Transcription regulator | 2.339 | 2.05E−19 | |
| Beta-estradiol | Chemical—endogenous mammalian | 3.237 | 4.04E−19 | |
| Tretinoin | Chemical—endogenous mammalian | 2.096 | 6.88E−19 | |
| Vegf | Group | 4.611 | 1.04E−18 | |
| PDGF BB | Complex | 3.059 | 1.07E−18 | |
| IL6 | Cytokine | 3.836 | 1.88E−18 | |
| dextran sulfate | Chemical—drug | 1.627 | 3.7E−18 | |
| SMAD7 | Transcription regulator | −1.759 | 5.52E−18 | |
| Medroxyprogesterone acetate | Chemical—drug | −2.449 | 5.52E−18 | |
| E2F4 | Transcription regulator | −0.927 | 3.52E−17 | |
| Alpha catenin | Group | −4.145 | 9.43E−17 | |
| PTGER2 | G-protein coupled receptor | 3.702 | 1.32E−16 | |
| IL-1β | 29.3 | Cytokine | 3.216 | 1.53E−16 |
| TGF-β | Group | 1.365 | 3.53E−16 | |
| Cycloheximide | Chemical—reagent | 0.371 | 5.29E−16 | |
| Dexamethasone | Chemical—drug | 0.526 | 1.41E−15 | |
| EP400 | Other | 3.148 | 2.43E−15 | |
| CDKN2A | Transcription regulator | −2.69 | 5.15E−15 | |
| Butyric acid | Chemical—endogenous mammalian | −0.573 | 8.37E−15 | |
| Trichostatin A | Chemical—drug | 1.112 | 1.77E−14 | |
| MYC | 4.2 | Transcription regulator | 2.574 | 2.78E−14 |
FIG 3Matrix metalloproteinase-7 (MMP-7) staining. (a) Luminal staining of MMP-7 (red) in crypts adjacent to a hyperplastic crypt (arrow). (b) Apical staining of MMP-7 (red) enterocytes in crypt.